1. Home
  2. Human Services
  3. Decatur, GA
  4. The Task Force for Global Health

The Task Force for Global Health

The Task Force for Global Health is ranked #7 of 15 human services organizations in Decatur, GA, with an America's Best Score of 74 out of 100, based on its 2025 Form 990.

  • Decatur, GA
  • Tax-exempt since 1986
  • EIN: 58-1698648
taskforce.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
74OF 100 #7 of 15 in Decatur ranked human services organizations How this score is calculated

Organization summary

The Task Force for Global Health is a 501(c)(3) organization, classified under Human Services (NTEE P30A). Contributions are tax-deductible.

330 W Ponce De Leon Ave, Decatur, GA 30030-2439

Among the 21 scored human services organizations in Decatur, The Task Force for Global Health holds 14.1 months of operating reserves (peer median 6.8 months), runs a typical yearly surplus of 11.3% (peers: surplus of 9.3%), and has grown spending 0.9% a year (peers: grown spending 20.4% a year).

In fiscal year 2025 it reported $114,019,244 in revenue and $89,589,214 in expenses, with contributions making up 96.8% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

The mission of The Task Force for Global Health is to solve large-scale health problems affecting populations through three impact areas: health system strengthening, center for vaccine equity, and neglected tropical diseases. These impact areas include programs such as pandemic preparedness, polio eradication, field epidemiology training, public health informatics, health workforce development, and medical surplus recovery.

Largest programs · fiscal year 2025

  • Respiratory Virus Prevention and Preparedness Programs Partnership for International Vaccine Initiatives (PIVI) Program Description: PIVI works to reduce global disease burden from influenza and improve capacity to respond to pandemic threats. Program Objectives: * FY2024: Increase programmatic experience and local evidence to drive government investment in national influenza vaccination programs.… Read more

    Respiratory Virus Prevention and Preparedness Programs Partnership for International Vaccine Initiatives (PIVI) Program Description: PIVI works to reduce global disease burden from influenza and improve capacity to respond to pandemic threats. Program Objectives: * FY2024: Increase programmatic experience and local evidence to drive government investment in national influenza vaccination programs. * Long-term: Establish sustainable national influenza vaccination programs to reduce global influenza burden and pandemic threat. Accomplishments: * Expanded to 28 partner countries (net growth of 7 countries during FY2024) * Donated 105,000 influenza vaccine doses (valued at $454,000) to 5 partner countries * Provided $1,120,000 in subawards to 17 partner countries * Supported 11 countries in transitioning from PIVI vaccine support to self-funded programs * Facilitated purchase of approximately 2,100,000 vaccine doses by transitioning countries * Documented improved vaccine access and coverage in 95% of partner countries with more than 1 year of support * Trained an estimated 500+ healthcare professionals in vaccine delivery and program management

    $17,729,120 spent · 23.7% of program spending
  • Funded principally by the Bill & Melinda Gates Foundation and the U.S. Agency for International Development, the NTD-SC supports Operational Research (OR) to eliminate neglected tropical diseases that threaten the lives and well-being of more than one billion people in some of the world's poorest communities, serving as the Secretariat for the Coalition for Operational Research on Neglected Tropic… Read more

    Funded principally by the Bill & Melinda Gates Foundation and the U.S. Agency for International Development, the NTD-SC supports Operational Research (OR) to eliminate neglected tropical diseases that threaten the lives and well-being of more than one billion people in some of the world's poorest communities, serving as the Secretariat for the Coalition for Operational Research on Neglected Tropical Diseases (COR-NTD). As of 2024, the NTD-SC managed a portfolio of more than 330 OR projects spanning 60 countries, and targeting all five neglected tropical diseases amenable to preventive chemotherapy: lymphatic filariasis, onchocerciasis, STH, schistosomiasis and trachoma, as well as other NTDs such as podoconiosis, leprosy and leishmaniasis. OR projects are designed to address challenges that prevent programs from achieving disease control and elimination goals and to inform World Health Organization (WHO) recommendations and guidance for NTD programs. In 2024, COR-NTD convened NTD Operational Research meetings in New Delhi, India and Brisbane, Australia in collaboration with regional WHO offices, ministries of health and local research partners, and completed the planning for a pioneering Africa-based operational research meeting on NTDs, in partnership with the African Research Network on NTDs, to take place in Kigali, Rwanda in early 2025. These regional conferences bring together researchers and country program managers and implementers to address the challenges faced by NTD programs that prevent the shared goal of eliminating these infections. With support from USAID in 2024, the NTD-SC also issued calls for proposals to support research focused on migrant and mobile populations and continued to support the African Research Network for Neglected Tropical Diseases (ARNTD) Small Grants Program. ARNTD manages a portfolio of research projects carried out by young African scientists at early stages of their careers and in 2024 the ARNTD call for proposals was also expanded to mid-career researchers for the first time. During the period, the NTD-SC also conducted a competitive process to identify Africa-based partners to transition the procurement of research supplies from a US-based to Africa-based supply chain.

    $11,223,673 spent · 15.0% of program spending
  • The International Trachoma Initiative (ITI) works tirelessly for a world free from trachoma. ITI contributes to eliminating trachoma as a public health threat by stewarding Pfizer's donation of azithromycin to treat and prevent the condition; building and strengthening partnerships to accelerate progress; and developing innovative tools to share data. Between September 2024 and August 2025, ITI or… Read more

    The International Trachoma Initiative (ITI) works tirelessly for a world free from trachoma. ITI contributes to eliminating trachoma as a public health threat by stewarding Pfizer's donation of azithromycin to treat and prevent the condition; building and strengthening partnerships to accelerate progress; and developing innovative tools to share data. Between September 2024 and August 2025, ITI organized just-in-time shipments of 44.6 million treatments for trachoma to be distributed at MDAs in 12 countries. As of August 2025, ITI has shipped more than 1.117 billion treatments to trachoma-endemic countries since the program's inception in 1999. ITI continued its data management support for Tropical Data, a free mobile phone-based service to support trachoma programs as they conduct prevalence surveys, providing them with robust data for decision-making on where antibiotic treatments are needed and where they can be stopped. Since its inception in February 2016, Tropical Data has supported over 4,136 surveys across 55 countries. As a key player in the global trachoma community, there have been tremendous achievements in reducing the population at risk of blindness from trachoma from an estimated 1.5 billion people in 2002 to 97.1 million in November 2025 according to the World Health Organization (WHO). ITI will continue to work smarter so that the dream of a trachoma-free world becomes a reality. In addition to ITI's work in trachoma, ITI was awarded a grant from the Gates Foundation in August 2024 to expand into the donation of azithromycin for child survival. Between September 2024 and August 2025, ITI organized just-in-time shipments of 22.8 million treatments for child survival to be distributed at MDAs in 3 countries.

    $10,837,819 spent · 14.5% of program spending
  • Public Health Informatics Institute $6,735,553 spent · 9.0% of program spending
  • Training Programs in Epidemiology and Public Health Interventions Network (TEPHINET) $6,390,197 spent · 8.5% of program spending

Where each dollar went · fiscal year 2025

Of every dollar it spent, 84¢ went to programs, 16¢ to management and 0¢ to fundraising.

  • Programs $74,828,583
  • Management $14,684,352
  • Fundraising $76,279

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score74 / 100
Rank in Decatur#7 of 15
DesignationRanked

Score breakdown

MeasureThis organizationPoints
Operating reserves14.1 mo; 6.5 mo in cash9.8 / 25
Financial balance (median margin)+11.3%18.4 / 20
Transparency4 full 990s, latest TY202520 / 20
Program growth+0.9% / yr7.9 / 15
Track record40 years10 / 10
Debt load20.6% of assets7.9 / 10
Total74 → 74
Spending on programs
Not scored; America's Best needs 65%+
84%Meets

Compared with Decatur peers

MeasureThis organizationPeer median
Operating reserves14.1 mo6.8 mo
Typical margin+11.3%+9.3%
Spending growth+0.9% / yr+20.4% / yr
Debt load20.6%0.0%

Peers: the 21 Decatur human services organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$114,019,244Fiscal year 20252022: $103,511,90920222023: $95,120,28520232024: $96,917,19420242025: $114,019,2442025
Expenses$89,589,214Fiscal year 20252022: $87,339,74020222023: $93,927,28220232024: $93,191,19920242025: $89,589,2142025
Total assets$132,481,029Fiscal year 20252022: $94,755,90920222023: $99,670,37620232024: $106,239,50220242025: $132,481,0292025
Total liabilities$27,232,852Fiscal year 20252022: $18,908,81420222023: $22,578,22420232024: $25,421,35520242025: $27,232,8522025
Fiscal year ending August 2025
Revenue$114,019,244
Expenses$89,589,214
Net income$24,430,030
Net assets$105,248,177

Notable sources of revenue

Percent of total revenue
Contributions$110,317,158
Program services$0
Investment income$3,702,086
Other (net)$0

Assets / debt

Total assets$132,481,029
Total liabilities$27,232,852
Net assets$105,248,177

Compensation

Not in our extract for this year.

Fiscal year ending August 2024
Revenue$96,917,194
Expenses$93,191,199
Net income$3,725,995
Net assets$80,818,147

Notable sources of revenue

Percent of total revenue
Contributions$90,341,313
Program services$0
Investment income$6,575,881
Other (net)$0

Assets / debt

Total assets$106,239,502
Total liabilities$25,421,355
Net assets$80,818,147

Compensation

Not in our extract for this year.

Fiscal year ending August 2023
Revenue$95,120,285
Expenses$93,927,282
Net income$1,193,003
Net assets$77,092,152

Notable sources of revenue

Percent of total revenue
Contributions$94,304,004
Program services$0
Investment income$871,890
Other (net)−$55,609

Assets / debt

Total assets$99,670,376
Total liabilities$22,578,224
Net assets$77,092,152

Compensation

Not in our extract for this year.

Fiscal year ending August 2022
Revenue$103,511,909
Expenses$87,339,740
Net income$16,172,169
Net assets$75,847,095

Notable sources of revenue

Percent of total revenue
Contributions$106,102,999
Program services$0
Investment income−$954,190
Other (net)−$1,636,900

Assets / debt

Total assets$94,755,909
Total liabilities$18,908,814
Net assets$75,847,095

Compensation

Officers and key employees$3,822,410
Share of expenses4.4%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?